FDA Lifts Clinical Hold on Insmed (INSM) ARIKACE in NTM Patients; Continues CF Negotiations
Go back to FDA Lifts Clinical Hold on Insmed (INSM) ARIKACE in NTM Patients; Continues CF Negotiations| INSMED (NASDAQ: INSM) | Delayed: 130.66 +2.20 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.46 | 52 Week High | $19.30 | |||
| Open | $129.85 | 52 Week Low | $9.02 | |||
| Day High | $131.10 | P/E | N/A | |||
| Day Low | $127.42 | EPS | $-1.69 | |||
| Volume | 1,493,477 | |||||
